Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 11

1.

mTORC2/Rac1 Pathway Predisposes Cancer Aggressiveness in IDH1-Mutated Glioma.

Liu Y, Lu Y, Li A, Celiku O, Han S, Qian M, Yang C.

Cancers (Basel). 2020 Mar 26;12(4). pii: E787. doi: 10.3390/cancers12040787.

2.

Computational modeling demonstrates that glioblastoma cells can survive spatial environmental challenges through exploratory adaptation.

Celiku O, Gilbert MR, Lavi O.

Nat Commun. 2019 Dec 13;10(1):5704. doi: 10.1038/s41467-019-13726-w.

3.

Metabolic Reprogramming Associated with Aggressiveness Occurs in the G-CIMP-High Molecular Subtypes of IDH1mut Lower Grade Gliomas.

Victor RR, Malta TM, Seki T, Lita A, Dowdy T, Celiku O, Cavazos-Saldana A, Li A, Liu Y, Han S, Zhang W, Song H, Davis D, Lee S, Trepel JB, Sabedot TS, Munasinghe J, Yang C, Herold-Mende C, Gilbert MR, Krishna Cherukuri M, Noushmehr H, Larion M.

Neuro Oncol. 2019 Oct 30. pii: noz207. doi: 10.1093/neuonc/noz207. [Epub ahead of print]

PMID:
31665443
4.

Mitochondrial NIX Promotes Tumor Survival in the Hypoxic Niche of Glioblastoma.

Jung J, Zhang Y, Celiku O, Zhang W, Song H, Williams BJ, Giles AJ, Rich JN, Abounader R, Gilbert MR, Park DM.

Cancer Res. 2019 Oct 15;79(20):5218-5232. doi: 10.1158/0008-5472.CAN-19-0198. Epub 2019 Sep 5.

PMID:
31488423
5.

Targeting IDH1-Mutated Malignancies with NRF2 Blockade.

Liu Y, Lu Y, Celiku O, Li A, Wu Q, Zhou Y, Yang C.

J Natl Cancer Inst. 2019 Oct 1;111(10):1033-1041. doi: 10.1093/jnci/djy230.

6.

Novel Targeting of Transcription and Metabolism in Glioblastoma.

Su YT, Chen R, Wang H, Song H, Zhang Q, Chen LY, Lappin H, Vasconcelos G, Lita A, Maric D, Li A, Celiku O, Zhang W, Meetze K, Estok T, Larion M, Abu-Asab M, Zhuang Z, Yang C, Gilbert MR, Wu J.

Clin Cancer Res. 2018 Mar 1;24(5):1124-1137. doi: 10.1158/1078-0432.CCR-17-2032. Epub 2017 Dec 18.

7.

Computational analysis of the mesenchymal signature landscape in gliomas.

Celiku O, Tandle A, Chung JY, Hewitt SM, Camphausen K, Shankavaram U.

BMC Med Genomics. 2017 Mar 9;10(1):13. doi: 10.1186/s12920-017-0252-7.

8.

Disabled cell density sensing leads to dysregulated cholesterol synthesis in glioblastoma.

Kambach DM, Halim AS, Cauer AG, Sun Q, Tristan CA, Celiku O, Kesarwala AH, Shankavaram U, Batchelor E, Stommel JM.

Oncotarget. 2017 Feb 28;8(9):14860-14875. doi: 10.18632/oncotarget.14740.

9.

Targeting MPS1 Enhances Radiosensitization of Human Glioblastoma by Modulating DNA Repair Proteins.

Maachani UB, Kramp T, Hanson R, Zhao S, Celiku O, Shankavaram U, Colombo R, Caplen NJ, Camphausen K, Tandle A.

Mol Cancer Res. 2015 May;13(5):852-62. doi: 10.1158/1541-7786.MCR-14-0462-T. Epub 2015 Feb 26.

10.

Visualizing molecular profiles of glioblastoma with GBM-BioDP.

Celiku O, Johnson S, Zhao S, Camphausen K, Shankavaram U.

PLoS One. 2014 Jul 10;9(7):e101239. doi: 10.1371/journal.pone.0101239. eCollection 2014.

11.

StRAP: an integrated resource for profiling high-throughput cancer genomic data from stress response studies.

Johnson S, Issac B, Zhao S, Bisht M, Celiku O, Tofilon P, Camphausen K, Shankavaram U.

PLoS One. 2012;7(12):e51693. doi: 10.1371/journal.pone.0051693. Epub 2012 Dec 17.

Supplemental Content

Loading ...
Support Center